|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
3/18/20‡ Acer Therapeutics Inc. 424B2 1:393K Donnelley … Solutions/FA
3/18/20 Acer Therapeutics Inc. S-8 3/18/20 4:57K Donnelley … Solutions/FA
3/18/20 Acer Therapeutics Inc. 10-K 12/31/19 60:6.4M ActiveDisclosure/FA
3/18/20 Acer Therapeutics Inc. 8-K:2,7,8,9 3/18/20 5:10M ActiveDisclosure/FA
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Types: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-K | Annual Report — Form 10-K. | | 424B2 | Prospectus – Primary Offering or Shelf Securities. | | S-8 | Registration Statement – Securities for an Employee Benefit Plan — Form S-8. |
|